These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29857970)

  • 1. Nivolumab-induced Limbic Encephalitis with Anti-Hu Antibody in a Patient With Advanced Pleomorphic Carcinoma of the Lung.
    Matsuoka H; Kimura H; Koba H; Tambo Y; Ohkura N; Hara J; Sone T; Kasahara K
    Clin Lung Cancer; 2018 Sep; 19(5):e597-e599. PubMed ID: 29857970
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple paraneoplastic antibodies (anti-SOX1, anti-Hu, and anti-Amphiphysin) detected in a patient with limbic encephalitis and small cell lung cancer.
    Fukuda TG; do Rosário MS; Branco RCC; Fukuda JS; de Souza E Souza RA; Oliveira-Filho J; de Jesus PAP
    Neurol India; 2017; 65(5):1127-1128. PubMed ID: 28879908
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-Hu-Associated Autoimmune Limbic Encephalitis in a Patient with PD-1 Inhibitor-Responsive Myxoid Chondrosarcoma.
    Papadopoulos KP; Romero RS; Gonzalez G; Dix JE; Lowy I; Fury M
    Oncologist; 2018 Jan; 23(1):118-120. PubMed ID: 29158368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic limbic encephalitis associated with lung cancer.
    Shen K; Xu Y; Guan H; Zhong W; Chen M; Zhao J; Li L; Wang M
    Sci Rep; 2018 May; 8(1):6792. PubMed ID: 29717222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute cerebellitis after administration of nivolumab and ipilimumab for small cell lung cancer.
    Naito T; Osaki M; Ubano M; Kanzaki M; Uesaka Y
    Neurol Sci; 2018 Oct; 39(10):1791-1793. PubMed ID: 29948463
    [No Abstract]   [Full Text] [Related]  

  • 6. Worsening of anti-Hu paraneoplastic neurological syndrome related to anti-PD-1 treatment: Case report and review of literature.
    Raibagkar P; Ho D; Gunturu KS; Srinivasan J
    J Neuroimmunol; 2020 Apr; 341():577184. PubMed ID: 32058173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encephalitis Induced by Durvalumab During Treatment of Metastatic Small-Cell Lung Cancer: Illustrative Case and Review of the Literature.
    Shechtman Y; Shalata W; Khoury R; Mahajna A; Weller B; Agbarya A
    J Immunother; 2021 Sep; 44(7):243-247. PubMed ID: 33734140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive-Stage Small-Cell Lung Cancer With Sustained Complete Response to Single-Agent Nivolumab and Immune-Related Dermatitis.
    Widick P; Gill RR; Mantia C; Costa DB; Rangachari D
    Clin Lung Cancer; 2020 Jan; 21(1):e6-e9. PubMed ID: 31640925
    [No Abstract]   [Full Text] [Related]  

  • 9. [Limbic encephalitis with antibodies against intracellular antigens].
    Morita A; Kamei S
    Brain Nerve; 2010 Apr; 62(4):347-55. PubMed ID: 20420174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Following sensory neuropathy, anti-Hu antibody-positive paraneoplastic neurological syndrome presenting with limbic encephalitis occurs after complete remission].
    Fukami Y; Umemura T; Shimono T; Yokoi T; Kamijo M; Sakakibara T
    Rinsho Shinkeigaku; 2013; 53(4):287-92. PubMed ID: 23603543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Widespread Nivolumab-induced Enteropathy in a Long Responder Non-Small-cell Lung Cancer Patient.
    Facchinetti F; Gnetti L; Caruana P; Fornaroli F; Luigi de'Angelis G; Sabato M; Ferri L; Cosenza A; Bordi P; Tiseo M
    Clin Lung Cancer; 2018 Sep; 19(5):e591-e596. PubMed ID: 29801705
    [No Abstract]   [Full Text] [Related]  

  • 12. Hu-antibody positive limbic encephalitis in a patient with Hodgkin lymphoma.
    Hentschke S; Malzfeldt E; Salwender HJ; Braumann D; Stang A; Hentschke M
    Leuk Lymphoma; 2008 Dec; 49(12):2374-6. PubMed ID: 19052989
    [No Abstract]   [Full Text] [Related]  

  • 13. Eczematous reactions mimicking psoriasiform dermatitis induced by nivolumab for advanced lung cancer.
    Tanaka M; Hoashi T; Ichiyama S; Noro R; Seike M; Kubota K; Gemma A; Funasaka Y; Saeki H
    Australas J Dermatol; 2019 Feb; 60(1):e67-e68. PubMed ID: 29896926
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-Hu-associated paraneoplastic limbic encephalitis in Hodgkin lymphoma.
    Laffon M; Giordana C; Almairac F; Benchetrit M; Thomas P
    Leuk Lymphoma; 2012 Jul; 53(7):1433-4. PubMed ID: 22136379
    [No Abstract]   [Full Text] [Related]  

  • 15. Rituximab for nivolumab plus ipilimumab-induced encephalitis in a small-cell lung cancer patient.
    Ito M; Fujiwara S; Fujimoto D; Mori R; Yoshimura H; Hata A; Kohara N; Tomii K
    Ann Oncol; 2017 Sep; 28(9):2318-2319. PubMed ID: 28911080
    [No Abstract]   [Full Text] [Related]  

  • 16. Nivolumab-Induced Fulminant Immune-Related Colitis Despite Infliximab in a Patient With NSCLC.
    Callens R; Tamsin A; van Zandweghe L
    J Thorac Oncol; 2019 Mar; 14(3):e49-e50. PubMed ID: 30782382
    [No Abstract]   [Full Text] [Related]  

  • 17. Lichen planus pemphigoides developing from patient with non-small-cell lung cancer treated with nivolumab.
    Sato Y; Fujimura T; Mizuashi M; Aiba S
    J Dermatol; 2019 Oct; 46(10):e374-e375. PubMed ID: 31062404
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-Hu antibody-positive paraneoplastic limbic encephalitis with acute motor sensory neuropathy resembling Guillain-Barré syndrome: a case study].
    Sakurai T; Wakida K; Kimura A; Inuzuka T; Nishida H
    Rinsho Shinkeigaku; 2015; 55(12):921-5. PubMed ID: 26511029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nivolumab-Induced Hemophilia A Presenting as Gastric Ulcer Bleeding in a Patient With NSCLC.
    Kato R; Hayashi H; Sano K; Handa K; Kumode T; Ueda H; Okuno T; Kawakami H; Matsumura I; Kudo M; Nakagawa K
    J Thorac Oncol; 2018 Dec; 13(12):e239-e241. PubMed ID: 30017828
    [No Abstract]   [Full Text] [Related]  

  • 20. Nivolumab and Ipilimumab-induced Acute Inflammatory Demyelinating Polyradiculoneuropathy: A Case Report.
    Pomerantz M; Lichtenstein DA; Niesvizky-Kogan I; Sohal R; Leibovitch J; Basnet A
    J Immunother; 2019; 42(9):348-349. PubMed ID: 31261166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.